TrademarkDir
NEOCIDE-3
LIVE

Serial Number

85273331

Owner

Molecular Therapeutics

First Use Date

Dec 1, 2002

Filing Date

Mar 22, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEOCIDE-3 Trademark

Serial Number: 85273331 • Registration: 4052461

NEOCIDE-3 is a trademark filed by Molecular Therapeutics on March 22, 2011. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Molecular Therapeutics (9 trademarks)

425 River Rd, Suite 422
Athens, GA 30602

Entity Type: 13

Trademark Details

Filing Date

March 22, 2011

Registration Date

November 8, 2011

First Use Anywhere

December 1, 2002

First Use in Commerce

January 1, 2003

Published for Opposition

August 23, 2011

Goods & Services

Antibacterial pharmaceuticals for veterinary use; Antibacterial substances for veterinary use; Dermatological pharmaceutical products for veterinary use; Pharmaceutical preparations and substances for veterinary use for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for veterinary use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for veterinary use for the treatment of infectious diseases; Pharmaceutical preparations for veterinary use for the treatment of skin lesions; Pharmaceutical preparations for veterinary use in dermatology; Pharmaceutical preparations for veterinary use for wounds; Pharmaceuticals, namely, anti-infectives for veterinary use; Therapeutic pharmaceutical for veterinary use for the treatment of skin lesions

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 22, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 22, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 22, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 5, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 8, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 2, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 2, 2019 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 25, 2018 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Aug 1, 2018 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 25, 2018 APRE
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 27, 2018 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 6, 2017 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 9, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 27, 2017 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 27, 2017 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 8, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 8, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 23, 2011 NPUB
PUBLISHED FOR OPPOSITION
Aug 23, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 21, 2011 PREV
ASSIGNED TO LIE
Jul 20, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 23, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 23, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 23, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 23, 2011 CNEA
ASSIGNED TO EXAMINER
Jun 20, 2011 DOCK
NOTICE OF PSEUDO MARK MAILED
Mar 29, 2011 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2011 NWOS
NEW APPLICATION ENTERED
Mar 25, 2011 NWAP

Related Trademarks

More from this Owner

SILVAKLENZ

SILVAKLENZ

SILVAKLENZ

SILVAKLENZ

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

SILVAKLENZ

SILVAKLENZ